Abstract P5-02-16: Thymidine kinase activity as a prognostic biomarker for first line CDK4/6 inhibitor efficacy in the Personalised Disease Monitoring in Metastatic Breast Cancer study
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Sacha Howell, Bergqvist Mattias, Williams Amy, Mouhanna Pia, Albu-Kareem Ahmed, Elinder Ellinor, Eriksson Olle, Kavanagh Amy, Larsson Karolina, Uminska Monika, Ekholm Maria
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411288198